Navigation Links
Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study
Date:11/9/2009

HOPKINTON, Mass., Nov. 9 /PRNewswire/ -- Facet Solutions, Inc. today announced that it has enrolled the 100th patient in its randomized, controlled ACADIA(TM) IDE study for lumbar spinal stenosis. "We are well ahead of our projections for 2009," stated President and CEO, Geoff Pardo. "It is indicative of the market need, the clinical outcomes that surgeons are seeing, and the ease with which they can implant ACADIA(TM)." Over 1.5 million people are diagnosed with lumbar spinal stenosis each year in the United States. Current treatment alternatives include fusion, which eliminates motion and can result in long recovery for patients.

Dr. Jim Youssef, orthopedic spine surgeon of SpineColorado in Durango, CO, remarked, "We are excited to be a part of this landmark study. Spinal stenosis is a common indication that I see in my practice, and the ability to offer patients a complete decompression while restoring motion and stability, is a very compelling proposition for both patient and surgeon."

Dr. Darryl DiRisio, neurosurgeon at Albany Medical Center in Albany, NY, added, "ACADIA(TM) is an easy to use system that has a minimal learning curve and fits into my surgical practice. What is exciting for these stenosis patients, in addition to the pain relief, is the potential for a quicker recovery over a traditional fusion."

Facet Solutions, Inc. has developed ACADIA(TM) to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The ACADIA(TM) procedure includes replacement of the diseased posterior spinal joints with an anatomic implant that is designed to restore the natural motion, stability, and balance to the lumbar spine.

Dr. Antonio Castellvi will be presenting a worldwide clinical update at the upcoming North American Spine Society meeting in San Francisco, CA on November 10th at 10:15am in room 300.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is certified to ISO 13485. ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

SOURCE Facet Solutions, Inc.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. First Human Implant of New Archus Orthopedics Facet Replacement System
4. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
5. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
6. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
7. DATATRAK eClinical(TM) Supports Multifaceted Studies
8. Facet Solutions Acquires Archus Orthopedics
9. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
10. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
11. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):